Clinical trial
The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using…
NCT05820087 · HistoSonics, Inc., Industry · Active, not recruiting
Key facts
| NCT number | NCT05820087 |
|---|---|
| Title | The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY) |
| Official title | The HistoSonics Edison System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY US) |
| Acronym | #HOPE4KIDNEY |
| Lead sponsor | HistoSonics, Inc., Industry |
| Status | Active, not recruiting |
| Study type | Interventional |
| Conditions | Renal Cancer, Tumor, Solid, Kidney Cancer, Benign |
| Intervention type | Device |
| Interventions | HistoSonics Edison System |
| Enrollment | 67 |
| Start date | Jan 4, 2024 |
| Primary completion | Sep 4, 2025 |
| Completion | Jul 1, 2030 |
| First posted | Apr 19, 2023 |
| Last update posted | Dec 22, 2025 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: